Elizabeth de Somer is the Chief Executive Officer of Medicines Australia, a position she has held since April 2018. In this role, she focuses on leading initiatives that support the innovative research-based biopharmaceutical industry. Her work emphasizes system-level health strategies to ensure Australian patients have access to breakthrough medicines, vaccines, and biotechnology therapies.